newsfilter
← Latest News
GlobeNewswire·

Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call

RICHMOND, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced that the company has scheduled the release of its third quarter 2025 financial